Data consistently demonstrates that a subset of patients with depression show elevated levels of inflammatory biomarkers including Interleukin-6 (IL-6), Interleukin-1Beta (IL-1β), Tumour Necrosis Factor-alpha (TNF- α) and CRP (Miller and Raison, 2016). This evidence concerns the gene IL6 and depressive symptom measurement.